Dow Up 0.19% Nasdaq Up 0.56%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.18 0.10(2.45%) Nov 20, 4:00PM EST
Prev Close:4.08
Open:4.05
Bid:4.16 x 500
Ask:N/A
1y Target Est:7.58
Beta:-4.53
Next Earnings Date:N/A
Day's Range:4.01 - 4.18
52wk Range:3.26 - 7.97
Volume:2,586,881
Avg Vol (3m):4,326,080
Market Cap:920.08M
P/E (ttm):N/A
EPS (ttm):-0.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNAUp 2.45%920.08M
GSK111.50B
OREX709.44M
RHHBY255.96B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):26.19
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.24
Quarterly EPS Est (Dec-14) :-0.11
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.95

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback